Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollo Foam is a UK-based foam conversion and materials company that supplies custom engineered polyethylene and polyurethane foam products for multiple industrial end markets. The company is not a biotech, pharma, or healthcare therapeutics developer; rather, it manufactures and converts foam materials into finished components and fitments. Its medical-related activity appears to consist of supplying foam products for healthcare applications such as orthotics, prosthetics, seating, wound dressing support materials, and short-term implant-related uses. Apollo Foam primarily serves as a commercial manufacturing and conversion business, with operations centered in the West Midlands and distribution to local, national, and international customers. For a biotech analyst, the key point is that this is a healthcare-adjacent materials supplier, not a life sciences R&D company with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apollo Foam.